位置:成果数据库 > 期刊 > 期刊详情页
Rho/ROCK 小径和神经新生: 为中央神经系统和眼的神经损坏的一个潜在的治疗学的目标
  • ISSN号:2222-3959
  • 期刊名称:《国际眼科杂志:英文版》
  • 时间:0
  • 分类:R774.6[医药卫生—眼科;医药卫生—临床医学]
  • 作者机构:Department of Ophthalmology, Ruijin Hospital Affiliated Medical School, Shanghai Jiaotong University, Shanghai 200025, China
  • 相关基金:Supported by National Nature Science Foundation of China (No.81070728);Shanghai 'Science and Technology Innovation Action Plan' Basic Research Key Project,China (No.11JC1407700 and 11 JC1407701);Shanghai Nature Science Foundation, China (No.08ZR1413900);Shanghai Leading Academic Discipline Project, China(No.S30205)
中文摘要:

· Rho-associated kinase (ROCK) is a serine/threonine kinase and one of the major downstream effectors of the small GTPase RhoA. The Rho/ROCK pathway is closely related to the pathogenesis of several central nervous system (CNS) disorders, and involved in many aspects of neuronal functions including neurite outgrowth and retraction. In the adult CNS, the damaged neuron regeneration is very difficult due to the presence of myelin-associated axon growth inhibitors such as Nogo, myelin-associated glycoprotein (MAG) and oligodendrocyte-myelin glycoprotein (Omgp), etc. The effects of these axon growth inhibitors are reversed by blocking the Rho/ROCK pathway in vitro, and the inhibition of Rho/ROCK pathway can promote axon regeneration and functional recovery in the injured CNS in vivo. In addition, the therapeutic effects of the Rho/ROCK inhibitors have also been demonstrated in some animal models and the Rho/ROCK pathway becomes an attractive target for the development of drugs for treating CNS disorders. In this review, we summarized on the effect of the Rho and the downstream factor ROCK in neural regeneration, and the potential therapeutic effect of Rho/ROCK inhibitors in the survival and axonal regeneration of retinal ganglion cells was also discussed. ·

英文摘要:

Rho-associated kinase (ROCK) is a serine/threonine kinase and one of the major downstream effectors of the small GTPase RhoA. The Rho/ROCK pathway is closely related to the pathogenesis of several central nervous system (CNS) disorders, and involved in many aspects of neuronal functions including neurite outgrowth and retraction. In the adult CNS, the damaged neuron regeneration is very difficult due to the presence of myelin-associated axon growth inhibitors such as Nogo, myelin-associated glycoprotein (MAG) and oligodendrocyte-myelin glycoprotein (Omgp), etc. The effects of these axon growth inhibitors are reversed by blocking the Rho/ROCK pathway 47 vitro, and the inhibition of Rho/ROCK pathway can promote axon regeneration and functional recovery in the injured CNS in viva In addition, the therapeutic effects of the Rho/ROCK inhibitors have also been demonstrated in some animal models and the Rho/ROCK pathway becomes an attractive target for the development of drugs for treating CNS disorders. In this review, we summarized on the effect of the Rho and the downstream factor ROCK in neural regeneration, and the potential therapeutic effect of Rho/ROCK inhibitors in the survival and axonal regeneration of retinal ganglion cell was also discussed.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《国际眼科杂志:英文版》
  • 主管单位:
  • 主办单位:中华医学会西安分会
  • 主编:
  • 地址:陕西省西安市
  • 邮编:710054
  • 邮箱:
  • 电话:
  • 国际标准刊号:ISSN:2222-3959
  • 国内统一刊号:ISSN:
  • 邮发代号:
  • 获奖情况:
  • 国内外数据库收录:
  • 美国化学文摘(网络版),荷兰文摘与引文数据库,荷兰医学文摘,美国生物医学检索系统,美国科学引文索引(扩展库),瑞典开放获取期刊指南
  • 被引量:25